"Collaborative Assessment and Management of Suicidality" (CAMS) in Comparison to "Treatment as Usual" (TAU) for Suicidal Patients: a Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Suicidal Ideation
- Sponsor
- Vestre Viken Hospital Trust
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Changes in scores on Beck's Scale for Suicide Ideation (BSSI)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Although suicide risk is highly prevalent among the patient population in mental health care, remarkably little research exists on effective treatments. Among a small set of novel approaches, CAMS is particularly promising. The investigators compare CAMS to TAU in a randomized controlled trial at four departments in Vestre Viken Hospital Trust, hypothesizing CAMS to be the superior approach. Primary outcome measures are suicidal ideation and suicide attempts, with secondary outcome measures including general symptoms of mental health problems. Changes in the outcome measures are compared between the two groups from baseline to 6 and 12 months after patients are included in the study. The study has the potential to impact the science of treating suicidal individuals and it could benefit the general public by establishing CAMS as an effective clinical approach for rapidly reducing suicide risk.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Significant suicide ideation on Beck's Scale for Suicide Ideation (score 13 and above). Informed consent to participate.
Exclusion Criteria
- •Active psychosis, cognitive or physical impairment or other problems that preclude the ability to understand the study procedures and provide informed consent, non-Norwegian speaking subjects
Outcomes
Primary Outcomes
Changes in scores on Beck's Scale for Suicide Ideation (BSSI)
Time Frame: From baseline to 6 and 12 months after patient is included in the study
Interview scale with 19 items that measures a patient's suicidal ideation at its worst point in the past 2 weeks.
Secondary Outcomes
- Norwegian Patient Registry (NPR) data(Yearly for five years after study inclusion)
- Changes in scores on The Outcome Questionaire 45 (OQ-45)(From baseline to 6 and 12 months after patient is included in the study)
- Changes in scores on Suicide Attempt Self-Injury Count (SASI-C)(changes from baseline to 6 and 12 months after patient is included in the study)